Basis: Trailing twelve months (TTM net income over the latest quarterly balance sheet). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on assets (ROA) high or low?
The return on assets (ROA) of 3.13% is 270% above its 5-year average of 0.85%, near the high end of its 5-year range (-7.68%–3.13%).
46.26% above its 12-month average of 2.14%.
Annual fiscal-year return on assets; no daily interpolation. Historical series through 2025-09-30.
RETURN ON ASSETS (ROA)
3.13%
RETURN ON ASSETS (ROA) AVG TTM
2.14%
RETURN ON ASSETS (ROA) AVG 3Y
2.52%
RETURN ON ASSETS (ROA) AVG 5Y
0.85%
RETURN ON ASSETS (ROA) AVG 10Y
1.51%
RETURN ON ASSETS (ROA) AVG 15Y
2.78%
RETURN ON ASSETS (ROA) AVG 20Y
2.88%
CURRENT VS TTM AVG
+46.26%
CURRENT VS 3Y AVG
+24.33%
CURRENT VS 5Y AVG
+269.69%
CURRENT VS 10Y AVG
+107.53%
CURRENT VS 15Y AVG
+12.78%
CURRENT VS 20Y AVG
+8.57%
SECTOR MEDIAN · HEALTHCARE
5.14%
median of 90 covered companies
CURRENT VS SECTOR MEDIAN
-39.11%
vs the sector median at left
Cencora, Inc.
Market Cap
$62.57B
Return on Assets (ROA)
3.13%
TTM Avg
2.14%
3Y Avg
2.52%
5Y Avg
0.85%
Market Cap
$63.88B
Return on Assets (ROA)
8.11%
TTM Avg
5.66%
3Y Avg
4.50%
5Y Avg
3.49%
Market Cap
$57.13B
Return on Assets (ROA)
-28.75%
TTM Avg
-24.02%
3Y Avg
-10.32%
5Y Avg
-0.33%
Market Cap
$54.94B
Return on Assets (ROA)
2.99%
TTM Avg
2.96%
3Y Avg
2.15%
5Y Avg
1.30%
Market Cap
$74.19B
Return on Assets (ROA)
4.08%
TTM Avg
2.99%
3Y Avg
3.50%
5Y Avg
3.82%
Market Cap
$49.00B
Return on Assets (ROA)
1.85%
TTM Avg
3.00%
3Y Avg
3.04%
5Y Avg
2.95%
Market Cap
$48.58B
Return on Assets (ROA)
7.25%
TTM Avg
19.91%
3Y Avg
18.29%
5Y Avg
17.04%
Market Cap
$80.51B
Return on Assets (ROA)
10.37%
TTM Avg
11.40%
3Y Avg
12.40%
5Y Avg
16.97%
| NAME | MARKET CAP | RETURN ON ASSETS (ROA) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Cencora, Inc. (COR) | $62.57B | 3.13% | 2.14% | 2.52% | 0.85% |
| Boston Scientific Corporation (BSX)vs › | $63.88B | 8.11% | 5.66% | 4.50% | 3.49% |
| Moderna, Inc. (MRNA)vs › | $57.13B | -28.75% | -24.02% | -10.32% | -0.33% |
| Cardinal Health, Inc. (CAH)vs › | $54.94B | 2.99% | 2.96% | 2.15% | 1.30% |
| Cigna Corporation (CI)vs › | $74.19B | 4.08% | 2.99% | 3.50% | 3.82% |
| Humana Inc. (HUM)vs › | $49.21B | 2.23% | 2.52% | 4.20% | 5.49% |
| Becton, Dickinson and Company (BDX)vs › | $49.00B | 1.85% | 3.00% | 3.04% | 2.95% |
| Edwards Lifesciences Corporation (EW)vs › | $48.58B | 7.25% | 19.91% | 18.29% | 17.04% |
| Regeneron Pharmaceuticals, Inc. (REGN)vs › | $80.51B | 10.37% | 11.40% | 12.40% | 16.97% |
| Teva Pharmaceutical Industries Limited (TEVA)vs › | $43.20B | 1.77% | -0.35% | -1.89% | -2.43% |
ROA
3.1%
ROE
86.0%
ROA = Net Income / Total Assets
Return on assets measures how efficiently a company generates profit from its total assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON ASSETS (ROA) |
|---|---|
| 2025-09-30 | 2.03% |
| 2024-09-30 | 2.25% |
| 2023-09-30 | 2.79% |
| 2022-09-30 | 3.00% |
| 2021-09-30 | 2.69% |
| 2020-09-30 | -7.68% |
| 2019-09-30 | 2.18% |
| 2018-09-30 | 4.40% |
| 2017-09-30 | 1.17% |
| 2016-09-30 | 4.25% |
| 2015-09-30 | -0.49% |
| 2014-09-30 | 1.28% |
| 2013-09-30 | 2.29% |
| 2012-09-30 | 4.66% |
| 2011-09-30 | 4.72% |
| 2010-09-30 | 4.41% |
| 2009-09-30 | 3.71% |
| 2008-09-30 | 2.05% |
| 2007-09-30 | 3.81% |
| 2006-09-30 | 3.66% |
| 2005-09-30 | 2.80% |
| 2004-09-30 | 4.02% |
| 2003-09-30 | 3.66% |
| 2002-09-30 | 3.08% |
| 2001-09-30 | 1.22% |
| 2000-09-30 | 4.03% |
| 1999-09-30 | 3.28% |
| 1998-09-30 | 3.25% |
| 1997-09-30 | 2.60% |
| 1996-09-30 | 2.99% |
